Results 171 to 180 of about 281,748 (215)

Cytogenetic abnormalities in polycythemia vera: phenotypic correlates and prognostic relevance in 669 informative cases. [PDF]

Haematologica
Iftikhar M, Rana M, Jadoon Y, Abdelmagid M, Reichard K, Mendoza CZ, Pardanani A, Tefferi A, Gangat N.   +8 more
europepmc   +1 more source

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera. [PDF]

Leukemia
Beauverd Y, Ianotto JC, Thaw KH, Sobas M, Sadjadian P, Curto-Garcia N, Shih LY, Devos T, Krochmalczyk D, Galli S, Bieniaszewska M, Seferynska I, McMullin MF, Armatys A, Spalek A, Waclaw J, Zdrenghea MT, Legros L, Girodon F, Lewandowski K, Bellosillo B, Samuelsson J, Abuin Blanco A, Cony-Makhoul P, Collins A, James C, Kusec R, Lauermannova M, Noya MS, Skowronek M, Szukalski L, Szmigielska-Kaplon A, Wondergem M, Dudchenko I, Gora-Tybor J, Laribi K, Kulikowska de Nałęcz A, Demory JL, Le Dû K, Zweegman S, Besses Raebel C, Skoda RC, Giraudier S, Griesshammer M, Kiladjian JJ, Harrison CN.   +45 more
europepmc   +1 more source

Population Pharmacokinetics-Pharmacodynamics and Exposure-Response of Ropeginterferon Alfa-2b in Chinese and Japanese Patients With Polycythemia Vera. [PDF]

Pharmacol Res Perspect
Qin A, Shimoda K, Suo S, Fu R, Kirito K, Wu D, Liao J, Chen H, Wu L, Su X, Gao Y, Sato T, Li Y, Zhang J, Shen W, Wang W, Zhang L, Jin J, Komatsu N.   +18 more
europepmc   +1 more source

Authors response comments on: Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study. [PDF]

Indian J Ophthalmol
Cicek MF, Oba T, Ağın A, Ayer M, Onder F.   +4 more
europepmc   +1 more source

High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera. [PDF]

Blood Adv
Gazda AJ, Pan D, Erdos K, Abu-Zeinah G, Racanelli A, Horn EM, Scandura JM.   +6 more
europepmc   +1 more source

Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.

, 1954
Louis R. Wasserman
openalex   +1 more source

A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) database. [PDF]

Ann Hematol
Reeves BN, Masarova L, Abu-Zeinah G, Hunter AM, Shatzel JJ, Qin A, Yoon CH, Cai LY, Wei YF, Mesa RA.   +9 more
europepmc   +1 more source

What is the optimal strategy for secondary prevention after venous thromboembolism in polycythemia vera? [PDF]

Hematology Am Soc Hematol Educ Program
Ajufo H, Vaughn J.
europepmc   +1 more source